These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4896867)

  • 21. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 22. Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview.
    Boulton AA; Eisenhofer G
    Adv Pharmacol; 1998; 42():273-92. PubMed ID: 9327897
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 24. [Monoamines and manic-depressive syndromes].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1967; 100(2):487-98. PubMed ID: 4873952
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 26. Blockade of norepinephrine uptake by N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride in rodents.
    Lippmann W
    Biochem Pharmacol; 1969 Oct; 18(10):2495-505. PubMed ID: 5403986
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 28. [Some data on the pathways of interaction of corticosteroids and catecholamines].
    Ruchkina AS
    Ukr Biokhim Zh; 1967; 39(1):96-101. PubMed ID: 5603052
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: The use of selective MAO inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Psychopharmacol Bull; 1974 Jul; 10(3):9-10. PubMed ID: 4419491
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the effect of various digitalis substances on monoamine oxidase activity in rat, guinea pig and cat brain].
    Popov N; Förster W
    Acta Biol Med Ger; 1966; 17(2):221-31. PubMed ID: 5983237
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
    Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of the inhibition of monoamine oxidases on the metabolism of catecholamines in essential hypertension].
    Bannò S; Maggi GC; Buzzetti A
    Policlinico Prat; 1966 Dec; 73(50):1669-79. PubMed ID: 5997388
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.
    Fuxe K; Holmstedt B; Jonsson G
    Eur J Pharmacol; 1972 Jul; 19(1):25-34. PubMed ID: 4403108
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of cortisone on some aspects of catecholamine metabolism].
    Ruchkina AS
    Ukr Biokhim Zh; 1966; 38(4):440-5. PubMed ID: 5999376
    [No Abstract]   [Full Text] [Related]  

  • 36. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL; Ascher JA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The action of 2-amino-4-(isothioureyl methyl)-thiazol dihydrochloride (Agr 307) on the catecholamines of the central nervous system in the rat. Possible inhibition of dopamine beta-hydroxylase].
    Brunaud M; Vallée E; Laborit H
    Agressologie; 1971; 12(2):113-8. PubMed ID: 5123844
    [No Abstract]   [Full Text] [Related]  

  • 38. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of nitrate explosives on adrenergic nerves.
    Kalin M; Kylin B; Malmfors T
    Arch Environ Health; 1969 Jul; 19(1):32-5. PubMed ID: 4977647
    [No Abstract]   [Full Text] [Related]  

  • 40. [Activity of mouse cerebral monoamine oxidase as a function of the means of administration of a MAO inhibitor].
    Levy J; Michel-Ber E
    Therapie; 1966; 21(3):633-44. PubMed ID: 5942129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.